We are 2-Methyl-2-thiopseudourea sulfate CAS:867-44-7 manufacturer and supplier in China, Pls send inquiry of to firstname.lastname@example.org of visit www.nbinno.com our official website should you have any interests
CAS No: 867-44-7
Product Name: 2-Methyl-2-thiopseudourea sulfate
S-methylisothiourea sulfuric acid salt
S-Methylisothiourea Hemisulfate Salt
S-methyl-2-thiopseudourea hydrogen sulfate
Boiling Point: 138.8ºC at 760 mmHg
Melting Point: 240-241 °C (dec.)(lit.)
Molecular Formula: C2H8N2O4S2
Molecular Weight: 188.226
Flash Point: 37.7ºC
Exact Mass: 187.992554
Storage condition: Store at RT
Stability: Stable. Incompatible with strong oxidizing agents.
Water Solubility: 260 g/L (20 ºC)
Appearance: White crystalline powder
Loss on drying: ≤1.0%
Intermediates of Pirimcard CAS: 23103-98-2.
Intermediates of Pirimioxyphos CAS: 36378-61-7.
Intermediates of ETHIRIMOL CAS: 23947-60-6.
Intermediates of DIMETHIRIMOL CAS: 5221-53-4.
Be used as pesticide intermediate.
Intermediate of 4-Hydroxydebrisoquine. S-Methyl-isothiouronium Hemisulfate is also a reagent used in the synthesis of strobilurin-pyrimidine derivatives for their anti-proliferative activity.
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Related News: Pharmaceutical intermediates and APIs belong to the fine chemical industry.4-Chloro-3-fluorobenzonitrile CAS:110888-15-8 In 2016, in order to promote the innovative development, transformation and upgrading of the pharmaceutical industry, the Development and Reform Commission led the compilation of the “Guiding Opinions on Promoting the Healthy Development of the Pharmaceutical Industry”, which put forward requirements for all aspects of the medical industry and specifically proposed support for the field of chemical raw materials. .Kojic Acid Dipalmitate CAS:79725-98-7 However, in the long run, as the bulk API market continues to fall, more and more companies will transition to specialty API companies, and competition will intensify in the future.N4-Acetylcytosine However, in the long run, as the bulk API market continues to fall, more and more companies will transition to specialty API companies, and competition will intensify in the future.However, in the long run, as the bulk API market continues to fall, more and more companies will transition to specialty API companies, and competition will intensify in the future.